Professor Max Crispin MBiochem, DPhil, FRSC, FRSB
Professor of Glycobiology

- Related links
- Personal homepage
Professor Max Crispin joined Biological Sciences from the Glycobiology Institute at the University of Oxford. He runs the Glycoprotein Therapeutics Laboratory which is predominantly focussed on developing anti-viral vaccines and new antibody-based therapies against cancer.
Understanding the structure and function of glycoproteins and how they can be engineered offers exciting routes to the development of new vaccines and therapeutics
Career History
Sept 2017-present: Professor of Glycobiology. University of Southampton, UK.
Oxford Glycobiology Institute, University of Oxford
May 2013-Aug 2017: Principal Investigator, Glycoprotein Therapeutics Laboratory.
Dec 2011-Aug 2017: University Research Lecturer.
Feb 2009-May 2013: Senior Research Associate, Laboratory of Dr Chris Scanlan.
Corpus Christi College, Oxford
Sep 2014-Aug 2017: Stipendiary Lectureship in Biochemistry, Director of Studies (Biochemistry).
Oriel College, Oxford
Feb 2017-Aug 2017: Senior Dean.
Sep 2014-Aug 2017: Against Breast Cancer Senior Research Fellow.
Sep 2008-Aug 2014: Fellow and Tutor in Biochemistry.
Sep 2007-Aug 2008: Lecturer in Biochemistry, Director of Studies (Biochemistry).
Division of Structural Biology, University of Oxford
Feb 2006-Feb 2009: Post-doc, Laboratories of Prof. E.Y. Jones FRS & Prof. D.I. Stuart FRS.
Academic Qualifications
2001-2005: DPhil in Biochemistry. University of Oxford, UK.